Orphenadrine Citrate and Risankizumab-rzaa topical
Determining the interaction of Orphenadrine Citrate and Risankizumab-rzaa topical and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: orphenadrine
Brand name: Norflex, Banflex, Orphenate, Flexoject, Flexon, Mio-Rel, Myolin, Orfro, Norflex Injectable, Antiflex
Synonyms: Orphenadrine
Generic Name: risankizumab
Brand name: Skyrizi
Synonyms: Risankizumab
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Orphenadrine Citrate-Risedronate
- Orphenadrine Citrate-Risedronate and Calcium
- Orphenadrine Citrate-Risedronate Delayed Release
- Orphenadrine Citrate-Risedronate Delayed-Release Tablets
- Orphenadrine Citrate-Risedronate Sodium
- Orphenadrine Citrate-Risedronate Tablets
- Risankizumab-rzaa topical-Orphenadrine Extended-Release Tablets
- Risankizumab-rzaa topical-Orphenadrine Injection
- Risankizumab-rzaa topical-Orphenadrine w/A.C.
- Risankizumab-rzaa topical-Orphenadrine, aspirin, and caffeine
- Risankizumab-rzaa topical-Orphenate
- Risankizumab-rzaa topical-Orphengesic